History

A list of downloadable documents created during development.

Background information

Atrial fibrillation (stroke prevention) - rivaroxaban: equality impact assessment - guidance development

Atrial fibrillation (stroke prevention) - rivaroxaban: final appraisal determination

Atrial fibrillation (stroke prevention) - rivaroxaban: appraisal consultation

Atrial fibrillation (stroke prevention) - rivaroxaban: appendix A - final matrix

Atrial fibrillation (stroke prevention) - rivaroxaban: appendix B - final scope

Atrial fibrillation (stroke prevention) - rivaroxaban: appendix C - response to consultee and commentator comments on the draft remit and draft scope (pre-referral)

Atrial fibrillation (stroke prevention) - rivaroxaban: appendix D - response to consultee and commentator comments on the provisional matrix of consultees and commentators

Atrial fibrillation (stroke prevention) - rivaroxaban: draft scope for consultation (pre-referral) - July 2010

Atrial fibrillation (stroke prevention) - rivaroxaban; provisional matrix (pre-referral) - July 2010